ライフサイエンスコーパス: microdialysis

1 riatal glutamate were measured using in vivo microdialysis.

2 FD in 3 h/day and were monitored with VMH FA microdialysis.

3 f neuronal networks in vivo, we used in vivo microdialysis.

4 yruvate in the vastus lateralis muscle using microdialysis.

5 EC and IC rats was determined using in vivo microdialysis.

6 ng of bisulfide variation in the effluent of microdialysis.

7 dialysate DA concentration as measured with microdialysis.

8 leus accumbens shell (NAcSh) through in vivo microdialysis.

9 rtex and dorsal striatum measured by reverse microdialysis.

10 s in prefrontal cortex measured with in vivo microdialysis.

11 ne and PGD2 contractions were measured using microdialysis.

12 ed brain Abeta half-life measured by in vivo microdialysis.

13 t received apoE infusions during brain Abeta microdialysis.

14 nd the caudate nucleus (n = 5) using in vivo microdialysis.

15 rstitial fluid (ISF), as measured by in vivo microdialysis.

16 DA release at 4 weeks as measured by in vivo microdialysis.

17 cose levels were measured continuously using microdialysis.

18 e nucleus accumbens decreased as measured by microdialysis.

19 amine output and metabolism was studied with microdialysis.

20 nd the RSC, which was confirmed with in vivo microdialysis.

21 l stimulation, electrophysiology and in vivo microdialysis.

22 etylcholine release was measured via in vivo microdialysis.

23 ial resolution than competitive methods like microdialysis.

24 ng indirect calorimetry, blood sampling, and microdialysis.

25 to metabolic crisis as measured by cerebral microdialysis.

26 ippocampus of young APP/PS1 mice via reverse microdialysis.

27 assessed pharmacologically using intradermal microdialysis.

28 s in mesolimbic MOR function suggested by DA microdialysis.

29 els in the NAc shell, as measured by in vivo microdialysis.

30 Affinity-enhanced microdialysis (AE-MD) has previously been used to improv

31 Cortical microdialysis and amperometric methods revealed that, wh

32 and after exposure to a female using in vivo microdialysis and analyzed using high-performance liquid

33 n interstitial VMH glutamate levels by using microdialysis and biosensors, 2) identified the receptor

34 .0 mg kg(-1): 2355+/-1026%) as measured with microdialysis and decrease in [(11)C]FLB 457 binding pot

35 We interpret this result to mean that both microdialysis and diffusion tensor magnetic resonance im

36 Using microdialysis and fast-scan cyclic voltammetry in rats,

37 Microdialysis and immunohistochemical studies were perfo

38 esponse in the nucleus accumbens via in vivo microdialysis and increased tegmental brain-derived neur

39 hypothesis that intraluminal application of microdialysis and metabolic parameters from the small in

40 Using in vivo microdialysis and microinjection of drugs into the mesol

41 emission tomography (PET), autoradiography, microdialysis and molecular biology in a putative domina

42 Microdialysis and PET experiments were performed to comp

43 We used in vivo microdialysis and pharmacological treatments in rats to

44 e IL-6, IL-8 and TNF-alpha collected by skin microdialysis and safety and tolerability of bilastine.

45 The physical lag time between microdialysis and the analytical signal was approximatel

46 1.1mg) that contained the region sampled by microdialysis and the site of kainate injection, intrace

47 ss multiple time scales, using complementary microdialysis and voltammetric methods during adaptive d

48 triatal extracellular dopamine levels (using microdialysis) and dopamine D2/D3 receptor binding (usin

49 l space of subcutaneous adipose tissue using microdialysis, and 39 specific episodes of spontaneous r

50 ure, brain oxygen tension (PbtO2), and brain microdialysis, and electrodes for electroencephalography

51 , behavioral analyses, pharmacology, in vivo microdialysis, and neuronal activity mapping to assess t

52 Combining neuronal ensemble recordings, microdialysis, and optogenetics, here we show that the b

53 A novel optogenetic-microdialysis approach allowed the measurement of extrac

54 A novel optogenetic-microdialysis approach allowed us to demonstrate that lo

55 A recently introduced in vivo optogenetic-microdialysis approach was used, which allows the measur

56 ranial pressure + brain tissue PO2+ cerebral microdialysis (area under the receiver-operating charact

57 icrodialysis probe is critical to the use of microdialysis as a neurochemical analysis technique.

58 We evaluated microdialysis as a tool for early ischemia detection in

59 two techniques - glucose clamps and in vivo microdialysis - as a means to dynamically modulate blood

60 The in vivo brain microdialysis assays demonstrated that R-MOD alone produ

61 Our in vivo microdialysis assays indicate that Abca1 deficiency sign

62 ested for selective recognition by combining microdialysis assays with simple isotope labeling and NM

63 thin the amygdala were measured with in vivo microdialysis, at baseline and in response to challenge

64 ed by the lactate/pyruvate ratio using brain microdialysis; both these systems were placed in the rig

65 Cerebral microdialysis, brain tissue oxygen, intracranial pressur

66 e have developed an online, high-throughput, microdialysis-capillary electrophoresis (MD-CE) assay fo

67 We have developed a high-throughput microdialysis-capillary electrophoresis (MD-CE) assay fo

68 Anisotropy reductions near microdialysis catheter insertion sites were highly corre

69 m radius white matter-masked region near the microdialysis catheter insertion sites.

70 A microdialysis catheter was placed in the lateral renal c

71 The pressure probe and microdialysis catheter were placed on the surface of the

72 uously spinal cord perfusion pressure, and a microdialysis catheter, to monitor hourly glycerol, glut

73 One hundred kilodalton cut-off microdialysis catheters were implanted at a median time

74 Microdialysis catheters were inserted into the abdominal

75 The ability of the in vitro microdialysis-CE instrument to monitor dynamic changes i

76 Ex vivo intradermal microdialysis combined with culture media analysis provi

77 In vivo microdialysis combined with HPLC/electrochemical detecti

78 Monitoring with microdialysis commenced on median (interquartile range)

79 ore than 16 h at 1 min time resolution using microdialysis coupled online to a capillary HPLC system

80 ing behavioral tasks was determined by brain microdialysis coupled to chromatographic-electrochemical

81 Using a 100 kDa microdialysis cut-off membrane the two proteolytic break

82 In vivo microdialysis demonstrated decreased release of DA after

83 Cerebral microdialysis demonstrated more frequent critical reduct

84 We hypothesized that IL as opposed to IP microdialysis detects small intestinal ischemia with hig

85 Using microdialysis, direct accumbal administration of 1 muM 6

86 ced DA overflow in the NAc was examined with microdialysis early and late during self-administration

87 monitoring of the variation of bisulfide in microdialysis effluents by using a nanoparticle-glutathi

88 Likewise, the administration of E2 by microdialysis, either in the hypothalamic paraventricula

89 Furthermore, rodent microdialysis experiments also demonstrated that oral ad

90 In vivo microdialysis experiments in rat brain demonstrated that

91 Microdialysis experiments indicated that STN-DBS decreas

92 In line with these observations, microdialysis experiments revealed that local blockade o

93 Furthermore, in vivo microdialysis experiments showed that the disruptive pep

94 elease in the mechanisms of STN DBS, further microdialysis experiments showed that when the 5-HT lowe

95 ore, we investigated by neuronal tracing and microdialysis experiments the possible targeting of the

96 al pharmacologic and real-time in vivo brain microdialysis experiments were performed on male prairie

97 tissue and in vivo in rat brain as shown by microdialysis experiments.

98 When assessed by in vivo microdialysis, extracellular kynurenic acid levels were

99 In Protocol 2, an intradermal microdialysis fibre was placed in the skin of the latera

100 ch diet, subjects were instrumented with two microdialysis fibres for the local delivery of Ringer so

101 ects were instrumented with four intradermal microdialysis fibres on the forearm and each randomly as

102 nisms mediating H2 S-induced vasodilatation, microdialysis fibres were perfused with Ringer solution

103 d cyclo-oxygenase (COX) signalling pathways, microdialysis fibres were perfused with Ringer solution

104 Four microdialysis fibres were placed in the forearm skin of

105 Four microdialysis fibres were placed in the forearm skin of

106 For functional studies, microdialysis fibres were placed in the forearm skin of

107 Four microdialysis fibres were placed in the skin of nine nor

108 Five microdialysis fibres were placed in the skin of nine nor

109 Ten subjects were equipped with four microdialysis fibres which were randomly assigned one of

110 an analysis, amino acids were sampled using microdialysis, fluorescently labeled in an online reacti

111 Rapid-sampling microdialysis for cortical [lactate] as a marker of tiss

112 Rapid-sampling microdialysis for cortical [lactate] as a marker of tiss

113 In vivo microdialysis for sampling of cancer cell-derived (human

114 ff-line detection from droplets collected by microdialysis for the eventual measurement of neuropepti

115 ed near infrared (NIR) sensor, combined with microdialysis, for continuous glucose monitoring.

116 PO2 less than 20 mm Hg (9% vs 20%), cerebral microdialysis glucose less than 1 mmol/L (22% vs 57%), a

117 In experiment 2, using microdialysis, GnRH and kisspeptin surges induced by E2

118 ing of cerebral extracellular chemistry with microdialysis has the potential for early detection of m

119 ination of behavioral, electrophysiological, microdialysis, immunohistochemical, and Western blot ass

120 ) was performed in conjunction with cerebral microdialysis in a cohort of severe TBI patients with ti

121 mM)-evoked dopamine release was measured by microdialysis in awake, freely moving rats.

122 Microdialysis in behaving mice confirmed that EE normali

123 release of OXT within the PVN as assessed by microdialysis in combination with a highly sensitive rad

124 We used bilateral microdialysis in freely behaving rats (n = 32), instrume

125 The NE release in the PFC was measured by microdialysis in freely moving mice (n = 55).

126 Microdialysis in freely moving rats revealed that SI was

127 ulation of hippocampal e[GABA] using in vivo microdialysis in freely moving rats.

128 study was to determine the role of cerebral microdialysis in monitoring the efficacy of fractionated

129 ersus with control antibody was monitored by microdialysis in patient-derived GD2-expressing neurobla

130 AMPH concentrations were measured via microdialysis in rat nucleus accumbens after intraperito

131 In vivo microdialysis in rat nucleus accumbens showed that i.v.

132 sing in vitro transporter assays and in vivo microdialysis in rat nucleus accumbens.

133 Using in vivo microdialysis in rats and mice, we demonstrate that intr

134 Thus, we employed microdialysis in rats trained to self-administer intrave

135 Similar findings were obtained by microdialysis in rodents subjected to 1 night of paradox

136 ithin the nucleus accumbens (NAc) by in vivo microdialysis in task-performing animals.

137 Here, we performed in vivo microdialysis in the PFC and NAc in rats following eithe

138 We performed microdialysis in the rat brain for 5 days, with and with

139 in lipid levels were indexed both by in vivo microdialysis in the VTA and lipid extractions from brai

140 Measured in samples obtained by striatal microdialysis in vivo, basal levels of tryptophan, kynur

141 y measured DA efflux in the PFC and NAc with microdialysis in well trained rats performing a probabil

142 uglycemic clamps with concurrent hippocampal microdialysis in young, awake, behaving APPswe/PS1dE9 tr

143 Microdialysis indicated that acute re-exposure to nicoti

144 n blood flow responses to graded intradermal microdialysis infusions of noradrenaline (NA) were measu

145 The infusion of an E2 antagonist via reverse microdialysis into the PVN or VMH attenuated the effect

146 In-line microdialysis is in this work hyphenated to electrotherm

147 ial pressure, brain tissue PO2, and cerebral microdialysis--is more accurate than intracranial pressu

148 olic crisis as measured by elevated cerebral microdialysis lactate/pyruvate ratio occurred during sei

149 Microdialysis lactate/pyruvate ratios were improved at c

150 Microdialysis levels of histamine, IL-6 and IL-8 assesse

151 In vivo experiments using microdialysis linked to a sensitive estrogen ELISA showe

152 erebrovascular pressure reactivity index and microdialysis markers glucose, lactate, pyruvate, glutam

153 There is growing interest in cerebral microdialysis (MD) for sampling of protein biomarkers in

154 Microdialysis (MD) is a useful sampling tool for many ap

155 ll bore silica capillary (ID 50 mum); inline microdialysis (MD) removes ions that would interfere wit

156 This system involved microdialysis (MD) sampling and fluorescence determinati

157 se concentration in living rat brain through microdialysis (MD) sampling in conjunction with (i) onli

158 nd a significant inverse correlation between microdialysis measured levels of tau 13-36 h after injur

159 We found that acute microdialysis measurements of the axonal cytoskeletal pr

160 Immunohistochemistry and brain microdialysis measurements were performed.

161 elf-stimulation (ICSS)) or with cannulae for microdialysis measures of nucleus accumbens dopamine (NA

162 ng of lead transfer across the permselective microdialysis membrane to mimic the diffusive transport

163 evice camera as the detector, the integrated microdialysis/microfluidic chip device achieved a detect

164 ial pressure, brain tissue PO2, and cerebral microdialysis monitoring (right frontal lobe, apparently

165 Microdialysis monitoring did not cause serious complicat

166 Here, we describe a bedside microdialysis monitoring technique for optimizing spinal

167 for spinal cord injury include pressure and microdialysis monitoring to optimize spinal cord perfusi

168 l outcome of NMU on NMUR2 was examined using microdialysis (n = 16).

169 the hippocampus in vivo using zero-net-flux microdialysis, negligible GABA is detected by dentate gr

170 However, neither microdialysis nor diffusion tensor magnetic resonance im

171 Reverse microdialysis of cholinergic antagonists within BF preve

172 lation was abolished by simultaneous reverse microdialysis of cholinergic receptor antagonists into B

173 cocaine self-administration in rats.In vivo microdialysis of CRF in the VTA demonstrated that CRF is

174 Microdialysis of GABAA receptor antagonists into the PnO

175 Doppler flowmetry, combined with intradermal microdialysis of l-N(G)-monomethyl-l-arginine, a nitric

176 ivating one IC in guinea pig with cooling or microdialysis of procaine, and recording neural activity

177 the contralateral IC by cryoloop cooling or microdialysis of procaine.

178 blood, CSF or brain tissue or during in vivo microdialysis of the brain.

179 Thus, we performed intracerebral microdialysis on mice bearing orthotopic human gliomas (

180 of cocaine and heroin determined by in vivo microdialysis, on the reinforcing effects of cocaine and

181 DA signaling was characterized with in vivo microdialysis or fast-scan cyclic voltammetry.

182 No safety concerns arose during either microdialysis or scanning.

183 and brain glucose concentrations measured by microdialysis (p < .0001).

184 Following microdialysis placement, subjects performed supine cycli

185 chip with enzymatic microreactor (EMR) to a microdialysis probe and evaluated the performance of thi

186 ostatic interaction between peptides and the microdialysis probe because modification increased recov

187 Distinct microdialysis probe configurations and membranes types w

188 The microdialysis probe construction and insertion procedure

189 acellular recordings performed proximal to a microdialysis probe during local infusion of vehicle, th

190 of the hippocampus was collected with a 2-mm microdialysis probe every 2 min for 5h.

191 Capitalized upon a concentric microdialysis probe immersed in synthetic gut fluids, th

192 Male Sprague-Dawley rats, implanted with a microdialysis probe into the MH, were treated with rever

193 e of the interface between the brain and the microdialysis probe is critical to the use of microdialy

194 easurements, the brain tissue containing the microdialysis probe tracks was examined by fluorescence

195 placed in-line between the syringe pump and microdialysis probe.

196 direct contact with the porous membrane of a microdialysis probe.

197 eletion by histology, electrophysiology, and microdialysis; probed neuronal activation by c-Fos immun

198 Microdialysis probes (n = 125) coupled to depth electrod

199 electrically evoked dopamine release next to microdialysis probes during the retrodialysis of dexamet

200 m that integrates with FDA-approved clinical microdialysis probes for continuous monitoring of human

201 ley rats were stereotaxically implanted with microdialysis probes in the ARC or PAG.

202 Even so, implanting microdialysis probes into brain tissue causes a penetrat

203 the penetration injury caused by implanting microdialysis probes into brain tissue.

204 As discussed here, using microdialysis probes tethered to the heart of conscious

205 Microdialysis probes were implanted into the hypoglossal

206 Microdialysis probes were implanted into the inguinal ad

207 Two microdialysis probes were inserted into the dermis on th

208 NR2A-containing receptors, perfused through microdialysis probes, markedly reduced cortex susceptibi

209 nductance were measured over two intradermal microdialysis probes, one perfused with ISO saline and t

210 nuclei than larger sampling devices, such as microdialysis probes.

211 less than that of the smallest conventional microdialysis probes.

212 ertebrates, we recently developed an in vivo microdialysis procedure in the mPOA of Japanese quail.

213 We conducted immunoblotting and in vivo microdialysis procedures in MA high/low drinking mice, a

214 Using in vivo microdialysis procedures, extracellular glutamate (GLUEX

215 Microdialysis provided an early warning of arterial occl

216 centration of glutamine measured by cerebral microdialysis reflected the beneficial effects of FPSA t

217 We hypothesized that in ALF cerebral microdialysis reflects the benefits of FPSA treatment on

218 nd a perfusate flow rate of 2.0 muL min(-1), microdialysis relative recoveries in the gastric phase w

219 Voltammetry measurements supported the microdialysis results by showing that nicotine withdrawa

220 The combination of the swelling and microdialysis results provides a fresh understanding on

221 Intracerebral microdialysis revealed a lower level of acetylcholine in

222 of hippocampal interstitial fluid by in vivo microdialysis revealed a significant elevation in lactat

223 Finally, no net-flux microdialysis revealed elevated basal glutamate and incr

224 The in vivo microdialysis revealed that alphaCaMKII(T286A) mice show

225 In the mPFC, in vivo microdialysis revealed that extracellular 5-HT levels we

226 In vivo microdialysis revealed that N/OFQ prevented dyskinesias

227 Nanoliter volumes of microdialysis sample are efficiently reacted with contin

228 In vivo cortical microdialysis samples the extracellular fluid adjacent t

229 Microdialysis samples were collected from female rats th

230 ted within suspected seizure onset sites and microdialysis samples were obtained during interictal pe

231 a proteins, were measured every 1-2 h in the microdialysis samples.

232 hemical dynamics in model cell systems using microdialysis sampling coupled with high-speed capillary

233 Microdialysis sampling in the brain is employed frequent

234 Microdialysis sampling is an essential tool for in vivo

235 asuring their concentration in vivo by using microdialysis sampling is challenging due to their low c

236 In vivo neurochemical monitoring using microdialysis sampling is important in neuroscience beca

237 y, we employed contrast-enhanced ultrasound, microdialysis sampling of skeletal muscle interstitium,

238 Microdialysis sampling of the brain is an analytical tec

239 nfirm cell viability and confluency over the microdialysis sampling region.

240 imentally validated by comparison of in situ microdialysis sampling results with in-line microfiltrat

241 s of the analysed compounds as a function of microdialysis sampling time.

242 In situ automatic microdialysis sampling under batch-flow conditions is he

243 Microdialysis sampling was coupled with online, high-spe

244 In this work, microdialysis sampling was coupled with segmented flow e

245 In vivo microdialysis showed that GABA(B) activation in the DRN

246 In addition, in vivo microdialysis showed that systemic U69,593 decreased ove

247 n blood flow was measured directly over each microdialysis site via laser-Doppler flowmetry (LDF).

248 At the end of cycling, all microdialysis sites were locally heated to 43 degrees C

249 d in three protocols: in Protocol 1 (n = 8), microdialysis sites were perfused with lactated Ringer s

250 Additional in vivo microdialysis studies also show that this compound decre

251 recognition task and water maze and in brain microdialysis studies at lower doses.

252 Microdialysis studies demonstrated that both R- and S-mo

253 In microdialysis studies i.v. PRE-084 did not significantly

254 R- and S-modafinil were also evaluated in microdialysis studies in the mouse nucleus accumbens she

255 Microdialysis studies revealed that both JJ-3-42 and lor

256 Microdialysis studies revealed that either systemic admi

257 Microdialysis studies were performed to evaluate dopamin

258 In microdialysis studies, 5bb increased the dopamine efflux

259 nt euglycemic-hyperinsulinemic clamp, muscle microdialysis studies, and muscle biopsies.

260 staglandin concentration by 62%, as shown in microdialysis studies.

261 To address these issues, we developed a microdialysis technique to analyze monomeric ISF tau lev

262 By use of in vivo microdialysis techniques in freely moving rats and micro

263 We employed advanced opioid microdialysis techniques that allow detection of extrace

264 s of fluorescent false neurotransmitters and microdialysis techniques to unveil that cocaine and meth

265 e cycle has mainly been studied in vivo with microdialysis techniques.

266 tape stripping/dermatopharmacokinetics, and microdialysis) techniques.

267 been successfully combined with subcutaneous microdialysis to continuously monitor glucose in rats.

268 We used microdialysis to deliver artificial extracellular fluid

269 The present study employed microdialysis to determine whether exposure to N(2)O sti

270 rate-limiting enzyme in GABA synthesis) and microdialysis to measure extracellular GABA levels in th

271 eriment 3), while concurrently using in vivo microdialysis to measure hippocampal ACh efflux.

272 Doppler flowmetry combined with intradermal microdialysis to measure skin blood flow (SkBF) during g

273 The current study used microdialysis to monitor changes in extracellular DA lev

274 cs of soluble Abeta economy in vivo, we used microdialysis to sample the brain interstitial fluid (IS

275 al models of self-administration and in vivo microdialysis to study the pharmacological actions of R-

276 re we used a (3)H-glutamate uptake assay and microdialysis to test the hypothesis that ceftriaxone re

277 The current study used reverse microdialysis to test the hypothesis that the preferenti

278 ites (88+/-4, 61+/-5%CVC(max)) and localized microdialysis treatment sites (all P > 0.05).

279 sphorylation) and glutamate release (in vivo microdialysis) upon ILC electrical stimulation.

280 elay, p = 0.150), intracranial pressure, and microdialysis values.

281 In vivo microdialysis was carried out in rat nucleus accumbens t

282 Brain microdialysis was done simultaneously.

283 Microdialysis was performed using a flow rate of 3 muL/m

284 In vivo microdialysis was used to investigate IFN-alpha effects

285 In vivo microdialysis was used to measure acute heroin-induced i

286 Intradermal microdialysis was utilized for up to 24h after drug appl

287 re, using a unique large pore-sized membrane microdialysis, we characterized soluble Abeta oligomers

288 ptical stimulation with simultaneous in vivo microdialysis, we demonstrated that optical stimulation

289 Using neurotoxic lesions and microdialysis, we examined whether the mPOA modulates co

290 Using in vivo microdialysis, we found that VU0152100 reversed amphetam

291 Finally, by in vivo microdialysis, we observed an increase in methyl HIS lev

292 is" probe to couple optogenetics and in vivo microdialysis, we report that optical stimulation of bas

293 Using in vivo microdialysis, we show that 24 h withdrawal from alcohol

294 Using in vivo microdialysis, we show that ISF Abeta concentrations in

295 Using microdialysis, we showed that the release of NE evoked i

296 nditioned place preference (CPP) and in vivo microdialysis were used to assess negative reinforcement

297 nally, estradiol microinjections followed by microdialysis were used to determine whether estrogenic

298 nset of ischemia earlier than intraperioneal microdialysis with higher sensitivity and specificity.

299 raphysiologic hyperinsulinemia, by combining microdialysis with oral glucose tolerance tests and eugl

300 sites continuously perfused via intradermal microdialysis with: (1) lactated Ringer solution (Contro